Trials / Completed
CompletedNCT06780345
Role of Vitamin C Infusion in Postoperative Mechanically Ventilated Neonates With Sepsis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 37 Weeks
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the effect of intravenous vitamin C infusion on septic mechanically ventilated full-term neonates who underwent surgical interventions regarding mechanical ventilation parameters, time to wean, and the need for inotropic support.
Detailed description
Neonatal sepsis is a syndrome featuring non-specific signs and symptoms of systemic infection accompanied by bacteremia in the first 28 days of extrauterine life. This condition is a public health problem that still contributes to mortality and morbidity in neonatal intensive care units (NICUs) in high, as well as low- and middle-income countries. Vitamins are essential micronutrients with key roles in many biological pathways relevant to sepsis. Some of these relevant biological mechanisms include antioxidant and anti-inflammatory effects, protein and hormone synthesis, energy generation, and regulation of gene transcription. Vitamin C, ascorbic acid, is a water-soluble essential micronutrient commonly found in plants, especially fruits. When absorbed, it dissociates at physiological pH to form ascorbate, the redox state of the vitamin most commonly found in cells. In addition to being a potent antioxidant, vitamin C is a cofactor for enzymes involved in protein and hormone synthesis, metabolic pathways for energy generation, and regulation of gene transcription.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Mechanically ventilated neonates will receive the usual protocol of sepsis and a placebo without vitamin C. |
| DRUG | Vitamin C | Mechanically ventilated neonates will receive the usual protocol of sepsis plus vitamin C with a loading dose of 0.5 gm /kg and a maintenance dose of 0.5 gm /kg/hour adjusted for six hours for 7-10 days. |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2023-08-01
- Completion
- 2023-08-01
- First posted
- 2025-01-17
- Last updated
- 2025-01-17
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06780345. Inclusion in this directory is not an endorsement.